Governance Cizzle Biotechnology Holdings Plc

PSL

GB00BNG2VN02

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:18 2026-03-06 am EST			5-day change	1st Jan Change
1.550 ^GBX	+10.71%		+14.81%	-

Feb. 23	Cizzle Biotechnology Holdings plc Provides an Update on Progress Towards the Accreditation and Launch of Its Proprietary Test for the Ciz1b Biomarker Test	CI
Feb. 23	Cizzle says process of preparing submission for CLIA near completion	AN

Executive Committee: Cizzle Biotechnology Holdings Plc

Manager

Positions heldSince

Dawn Coverley

61 year

Chief Tech/Sci/R&D Officer

2025-01-01

Nigel Lee

65 year

Director of Finance/CFO

2021-05-13

Composition of the Board of Directors: Cizzle Biotechnology Holdings Plc

Director

CommitteesSince

Allan Syms

69 year

Chairman

2019-05-20

John Treacy

44 year

Audit Committee Chair
Compensation Committee Chair	2021-07-13
Audit Committee	2021-07-13
Nominating Committee Chair
Compensation Committee

Edwin Bower

60 year

Audit Committee	2025-03-24
Organization Committee	2025-03-24

Dawn Coverley

61 year

Audit Committee	2021-05-13
Compensation Committee	2021-05-13

Nigel Lee

65 year

Director/Board Member

2021-05-13

Latest Appointments: Cizzle Biotechnology Holdings Plc

25-03-25	Cizzle Biotechnology Holdings Plc Announces Board and Committee Changes	CI
25-01-02	Cizzle Biotechnology appoints Founder Dawn Coverley as CSO	AN
25-01-02	Cizzle Biotechnology Appoints Chief Scientific Officer	MT
25-01-02	Cizzle Biotechnology Holdings plc Appoints Dawn Coverley as Chief Scientific Officer	CI
24-04-02	MaxCyte inks deal with Be Bio; Orcadian firms farmout	AN
23-04-27	Ceiba net asset value down, up for Asia Dragon Trust	AN
22-12-23	TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact	AN

More news

Former Officers and Directors: Cizzle Biotechnology Holdings Plc

Insider

Positions held

SinceUntil

Martin Lampshire

Director/Board Member

2019-01-10

2021-05-13

Jonathan Freeman

Director/Board Member	2012-03-27	2015-05-11
Chairman	2015-04-11	2019-05-20
Independent Dir/Board Member	2012-03-27	2019-05-20

James Stuart McKenzie

Director/Board Member	2007-02-28	2019-01-30
Chief Executive Officer	2007-02-28	2019-01-30
Founder	2007-02-28	2019-01-30

Majd E. Zoorob

Director/Board Member	2007-02-28	2019-01-21
Chief Tech/Sci/R&D Officer	2007-02-28	2019-01-21
Founder	2007-02-28	2019-01-21

Philip Marshall

Director/Board Member

2013-08-01

2015-12-31

Andrew Nelson

Director/Board Member	2015-05-11	2015-12-07
Chairman	2010-12-28	2015-05-11

Russell Banks

Director/Board Member	2013-04-01	2015-01-28
Director of Finance/CFO	2013-04-01	2015-01-28

David McTurk

Chief Operating Officer

2014-10-28

Bryan Lawrence

Corporate Officer/Principal

2014-10-28

David John Holloway

Corporate Officer/Principal

2012-09-02

2013-04-01

Ceri Marc Jones

Director/Board Member	2010-12-28	2012-05-24
Director of Finance/CFO	2010-12-28	2012-05-24

Fenella Frost

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	5
Female	0

Of which Executive Committee

Male	2
Female	0

Of which Directors

Male	5
Female	0

Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable plasma biomarker, a variant of CIZ1 known as CIZ1B. CIZ1 is a cell nuclear protein involved in deoxyribonucleic acid (DNA) replication, and the targeted CIZ1B variant is correlated with early-stage lung cancer. Its prototype confirmative test has been developed to address the false positive rates of computed tomography (CT) scanning. The test is intended to address a clear unmet clinical need, which is early detection of lung cancer, when curative surgical resection is possible.

Employees

Sector

Biotechnology & Medical Research

More about the company